This discrepancy may be due to the use of human and mouse models, where HEVs are more susceptible to the regulatory effects of VEGF in mouse TDLNs, and this observation has also been confirmed in CNE2 tumor model mice (15). This evidence concerns the gene VEGFA and neoplasm.